Coya Therapeutics, Inc. COYA
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | -6.64M | -7.21M | -5.71M | -2.12M | -6.10M |
| Total Depreciation and Amortization | 2.80K | 2.80K | 6.80K | 6.80K | 6.80K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 945.60K | 2.21M | 2.88M | 1.59M | 1.04M |
| Change in Net Operating Assets | -1.69M | -1.21M | 1.82M | -608.50K | -720.90K |
| Cash from Operations | -7.38M | -6.21M | -1.01M | -1.13M | -5.77M |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -1.70K | -885.00K | -648.60K | -516.00K | -- |
| Cash from Investing | -1.70K | -885.00K | -648.60K | -516.00K | -- |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -- | 11.00M | 20.35M | 19.10K | 0.00 |
| Repurchase of Common Stock | -41.80K | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -124.30K | -- | -- | -- | -- |
| Cash from Financing | -166.10K | 11.00M | 20.35M | 19.10K | 0.00 |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -7.54M | 3.90M | 18.69M | -1.63M | -5.77M |